| Literature DB >> 24940451 |
Shaoyi Zhang1, Lele Ren1, Yousheng Li1, Jian Wang1, Wenkui Yu1, Ning Li1, Jieshou Li1.
Abstract
The aim of the present study was to retrospectively analyze the bacteriology and drug susceptibility of pus flora from abdominal trauma patients with severe intra-abdominal infection (SIAI). A total of 41 patients with SIAI induced by abdominal trauma were enrolled in the study, from which 123 abdominal pus samples were obtained. The results from laboratory microbiology and drug sensitivity were subjected to susceptibility analysis using WHONET software. A total of 297 strains were isolated in which Gram-negative bacteria, Gram-positive bacteria and fungi accounted for 53.5 (159/297), 44.1 (131/297) and 0.7% (2/297), respectively. Anaerobic bacteria accounted for 1.7%. The five predominant bacteria were Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Klebsiella pneumoniae (K. pneumoniae), Enterococcus faecalis and Pseudomonas aeruginosa (P. aeruginosa). E. coli was highly susceptible to cefoperazone (91%) and imipenem (98%), while Gram-positive cocci were highly susceptible to teicoplanin (100%) and linezolid (100%). S. aureus was 100% susceptible to vancomycin and K. pneumoniae was highly susceptible to imipenem (100%) and amikacin (79%). P. aeruginosa was the most susceptible to ciprofloxacin (90%). Gram-negative bacterial infection was present in the majority of cases of SIAI. However, a large number of patients were infected by Gram-positive bacteria, particularly S. aureus that exhibited significant resistance to penicillin (100%), oxacillin (100%) and a third-generation cephalosporin antibiotic cefotaxime (95%). Amongst the pathogenic bacteria that cause SIAI, both Gram-negative and Gram-positive bacteria account for a high proportion, so high-level and broad-spectrum antibiotics should be initially used.Entities:
Keywords: abdominal trauma; bacteriology; pus; severe intra-abdominal infection
Year: 2014 PMID: 24940451 PMCID: PMC3991502 DOI: 10.3892/etm.2014.1609
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Statuses of the 274 abdominal injury patients.
| Injury type | Cases, n |
|---|---|
| Simple abdominal wall injury | 31 |
| Abdominal viscera and retroperitoneal injuries | 219 |
| Hepatorrhexis | 49 |
| Splenic rupture | 77 |
| Renal contusion | 23 |
| Pancreatic injury | 68 |
| Gastric and duodenal injuries | 53 |
| Small intestine rupture | 24 |
| Colon rupture | 10 |
| Complicated brain, chest, bone and urinary system injuries | 24 |
Single organ injury, 165 cases; multiple organ injury, 54 cases.
Figure 1Screening of subjects. IAI, intra-abdominal infection.
Distribution of 297 pathogenic microbial strains.
| Type of pathogenic microbe | Strains (n) | Proportion (%) |
|---|---|---|
| Gram-positive bacteria | 131 | 44.1 |
| | 66 | 22.2 |
| | 28 | 9.4 |
| | 19 | 6.4 |
| | 12 | 4.0 |
| | 6 | 2.0 |
| Gram-negative bacteria | 159 | 53.5 |
| | 72 | 24.2 |
| | 34 | 11.4 |
| | 21 | 7.1 |
| | 8 | 2.7 |
| | 5 | 1.7 |
| | 3 | 1.0 |
| | 3 | 1.0 |
| | 2 | 0.7 |
| | 2 | 0.7 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| Anaerobic bacteria | 5 | 1.7 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| | 1 | 0.3 |
| Fungi | 2 | 0.6 |
| | 1 | 0.3 |
| | 1 | 0.3 |
Percentages of R, I and S strains of five main pathogenic bacteria to common antibiotics.
|
|
|
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotics | R | I | S | R | I | S | R | I | S | R | I | S | R | I | S |
| Amikacin | 11 | 8 | 81 | 22 | 5 | 73 | 12 | 9 | 79 | 64 | 4 | 32 | 19 | 5 | 76 |
| Gentamicin | 60 | 2 | 38 | 33 | 5 | 62 | 26 | 6 | 68 | 75 | 7 | 18 | 24 | 14 | 62 |
| Ampicillin | 49 | 22 | 29 | 39 | 6 | 55 | 100 | 0 | 0 | 43 | 7 | 50 | 100 | 0 | 0 |
| Piperacillin | 83 | 17 | 0 | 91 | 0 | 9 | 100 | 0 | 0 | - | - | - | 86 | 14 | 0 |
| Cefazolin | 61 | 7 | 32 | 36 | 3 | 61 | 100 | 0 | 0 | - | - | - | - | - | - |
| Cefuroxime | 61 | 3 | 36 | 28 | 5 | 67 | 100 | 0 | 0 | - | - | - | - | - | - |
| Cefotaxime | 58 | 3 | 39 | 95 | 5 | 0 | 32 | 6 | 62 | - | - | - | 48 | 38 | 14 |
| Ceftazidime | 58 | 6 | 36 | - | - | - | 29 | 6 | 65 | - | - | - | 19 | 19 | 62 |
| Cefoperazone | 4 | 5 | 91 | - | - | - | 24 | 3 | 73 | - | - | - | 90 | 10 | 0 |
| Aztreonam | - | - | - | - | - | - | - | - | - | - | - | - | 90 | 10 | 0 |
| Imipenem | 1 | 1 | 98 | - | - | - | 0 | 0 | 100 | - | - | - | 67 | 5 | 28 |
| Ciprofloxacin | 58 | 11 | 31 | 94 | 6 | 0 | 23 | 12 | 65 | 57 | 18 | 25 | 5 | 5 | 90 |
| Piperacillin | 83 | 6 | 11 | - | - | - | 12 | 15 | 73 | - | - | - | 24 | 0 | 76 |
| Paediatric compound sulfamethoxazole | - | - | - | 67 | 6 | 27 | - | - | - | - | - | - | 81 | 19 | 0 |
| Vancomycin | - | - | - | 0 | 0 | 100 | - | - | - | 0 | 14 | 86 | - | - | - |
| Erythromycin | - | - | - | 85 | 5 | 10 | - | - | - | 29 | 7 | 64 | - | - | - |
| Penicillin | - | - | - | 100 | 0 | 0 | - | - | - | - | - | - | - | - | - |
| Oxacillin | - | - | - | 100 | 0 | 0 | - | - | - | - | - | - | - | - | - |
| Clindamycin | - | - | - | 85 | 6 | 9 | - | - | - | - | - | - | - | - | - |
| Phosphonomycin | - | - | - | 36 | 0 | 64 | - | - | - | - | - | - | - | - | - |
| Teicoplanin | - | - | - | 0 | 0 | 100 | - | - | - | 0 | 0 | 100 | - | - | - |
| Linezolid | - | - | - | 0 | 0 | 100 | - | - | - | 0 | 0 | 100 | - | - | - |
R, resistant; S, susceptible; I, intermediate; E. coli, Escherichia coli; S. aureus, Staphylococcus aureus; K. pneumoniae, Klebsiella pneumoniae; E. faecalis, Enterococcus faecalis; P. aeruginosa, Pseudomonas aeruginosa.
Figure 2An SIAI patient undergoing multiple open abdominal surgeries following a car accident. SIAI, severe intra-abdominal infection.